# Self Selection Trial of Naproxen Sodium

> **NCT01383486** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 253 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Naproxen sodium ER (BAYH6689)
- **DRUG:** Advil

## Key facts

- **NCT ID:** NCT01383486
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2015-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383486, "Self Selection Trial of Naproxen Sodium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01383486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*